Cavanagh William (CIK 0001503593)

Latest company ownership

CATX - Perspective Therapeutics, Inc.

Role: Chief R&D Officer

Shares held

475,000

Last filed at

Aug 1, 2022

Confidence Score

50.0

2025Q4

Confidence Score History

2014Q2 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Oct 22, 2020	Oct 28, 2020	Perspective Therapeutics, Inc.	Chief R&D Officer	Buy	90.0	+7,692	38.46%	✗	$4K
Nov 15, 2019	Nov 19, 2019	Perspective Therapeutics, Inc.	Chief R&D Officer	Buy	90.0	+10,000	100.00%	✗	$3.9K
Nov 16, 2018	Nov 16, 2018	Perspective Therapeutics, Inc.	COO	Buy	90.0	+10,000	100.00%	✗	$4K
Apr 2, 2015	Apr 28, 2015	Perspective Therapeutics, Inc.	President	Sell	26.3	-13,340	-100.00%	✗	$20.4K
May 27, 2014	Jul 2, 2014	Perspective Therapeutics, Inc.	President	Sell	22.5	-30,571	-100.00%	✗	$67.9K
May 27, 2014	Jun 24, 2014	Perspective Therapeutics, Inc.	President	Sell	22.5	-30,571	-100.00%	✗	$67.9K